About Annexon (ANNX)
Annexon, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of therapies for patients with classical complement-mediated disorders of the body, brain and eye. The Company’s pipeline is based on its platform technology... Read more
- USD2.65
- USD2.69
- USD2.42
- USD8.40
- -11.30%
- --
- 894.96k
- 1.04M
- 303M
- 2.30
- -42.00%
Stock News
25 minutes ago
Ulta Beauty CEO says investments in growth ‘will take time’ to pay off, but shares still rally
MarketWatch
32 minutes ago
These proposed tax cuts and benefits could help caregivers in crisis — if they can get through Congress
MarketWatch
58 minutes ago
This ETF plays defensively within growth stocks. Here’s how it’s faring better than the S&P 500.
MarketWatch
1 hour ago
Almonds, whiskey, auto parts: EU's retaliatory tariffs set up these U.S. states and local products as the biggest losers
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
